ArticleProceedings of the National Academy of Sciences of the United States of America2026

FDA must regulate stem cell therapies to mitigate risks to patients and the public.

Taylor Pike et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.